Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 70

Sort by

Sort Order Select

Journal Articles

Clinical, Hematological, Genetic, and Pathological Significance in Newly Diagnosed High Grade B-Cell Lymphoma and Diffuse Large B-Cell Lymphoma

Qingyuan Qu, Lingyan Zhang, Chao Xue, Xueling Ge, PhD, Xiao Lv, Kang Lu, MD PhD, Xin Wang, MD PhD, Yujie Jiang, MD

Blood (2019) 134 (Supplement_1): 5339.

https://doi.org/10.1182/blood-2019-129629

Published: 2019

Journal Articles

A Longitudinal Study in Elderly Patients with Non-Transfusion Dependent Thalassemia (NTDT) Emphasizes the Size of Splenomegaly Predicts Transfusion Requirement Later in Life

Supachai Ekwattanakit, PhDMD, Vip Viprakasit, MD DPhil

Blood (2019) 134 (Supplement_1): 2250.

https://doi.org/10.1182/blood-2019-122296

Published: 2019

Journal Articles

Patterns of Renal Recovery and Toxicity with Novel Agent-Based Induction Triplets in Newly Diagnosed Multiple Myeloma - an Analysis of Two Prospective Studies By the German DSMM Myeloma Study Group

Blood (2019) 134 (Supplement_1): 1840.

https://doi.org/10.1182/blood-2019-125235

Published: 2019

Journal Articles

Predictive Value of Cellular Blood Indices for All-Cause Mortality in Acute Pulmonary Embolism

Brett Slajus, Yevgeniy Brailovsky, DO, Trung Phan, Iman Darwish, Jawed Fareed, PhD, Amir Darki, MD MSc

Blood (2019) 134 (Supplement_1): 2103.

https://doi.org/10.1182/blood-2019-127425

Published: 2019

Journal Articles

Neutropenia in Children Treated with Deferiprone or Deferasirox: A Report of the Largest Randomized Trial of Oral Chelators in Transfusion-Dependent Pediatric Patients

Fernando Tricta, MD, Mariagrazia Felisi, PhD, Oscar Della Pasqua, Amal El-Beshlawy, MD, Hoda Hassab, MD, Antonis Kattamis, Manika Kreka, MD, Giorgio Reggiardo, Laila Metwally Sherief, MD, Michael Spino, PharmD, Bianca Tempesta, PhD, Yu-Chung Tsang, PhD, Adriana Ceci, MD

Blood (2019) 134 (Supplement_1): 3552.

https://doi.org/10.1182/blood-2019-127933

Published: 2019

Journal Articles

The Revised Myeloma Comorbidity Index (R-MCI) As a Promising Approach for Predicting Overall (OS)- and Progression-Free (PFS) Survival and Optimizing Therapy Strategies in Multiple Myeloma (MM) Patients (pts) - Comparative Analysis of 5 Comorbidity Indices (CI), Including Retro- and Prospective Applicability

Katja Schoeller, Gabriele Ihorst, Sophia Scheubeck, Max Holler, Sandra M. Woerner, Heike Reinhardt, Stefan P. Müller, Justus Duyster, MD, Ralph Wäsch, MD, Monika Engelhardt, MD

Blood (2019) 134 (Supplement_1): 3474.

https://doi.org/10.1182/blood-2019-127030

Published: 2019

Journal Articles

Outcomes of Follicular Lymphoma Patients Treated with Frontline Bendamustine and Rituximab: Impact of Histologic Grade and Early Progression on Overall Survival

Allison M. Winter, MD, Loretta J. Nastoupil, MD, Melody R. Becnel, MD, James R. Cerhan, MD PhD, Thomas M. Habermann, MD, Brian K. Link, MD, Matthew J. Maurer, MS, Bita Fakhri, MD MPH, Prathima Reddy, MD, Stephen D. Smith, MD, Dhruvika Mukhija, MD, Deepa Jagadeesh, MD MPH, Amrita Desai, MD, Juan Pablo Alderuccio, MD, Izidore S. Lossos, MD, Pooja Mehra, MD, Craig A. Portell, MD, Christopher R. D'Angelo, MD, Vaishalee P. Kenkre, MD, Max L. Goldman, MD, Oscar Calzada, BS, Jonathon B. Cohen, MD MS, Mohammad Junaid Hussain, MD, Nilanjan Ghosh, MD PhD, Yang Liu, MD, Stefan Klaus Barta, MD MRCP, MS, Paolo F Caimi, MD, Adam Kittai, MD, Alexey V Danilov, MD PhD, Timothy Tiutan, MD, Peter Martin, FRCPC, MD MS, Nathalie Danielson, MSN, RN, ACNP-BC, Manali Kamdar, MD, Abhigna Kodali, MD, Andrew M. Evens, DO, MSc, Brad S Kahl, MD, Brian T. Hill, MD PhD

Blood (2018) 132 (Supplement 1): 4146.

https://doi.org/10.1182/blood-2018-99-118530

Published: 2018

Journal Articles

Deubiquitinase OTUD7B Is Potential Prognostic Biomarker in Diffuse Large B-Cell Lymphoma

Qunling Zhang, MD PhD, Juan Gu, MD PhD, Kai Xue, MD, Zuguang Xia, Cory Mavis, BSc, MSc, Francisco J. Hernandez-Ilizaliturri, MD, Ye Guo, Xiaonan Hong, Junning Cao, MD

Blood (2018) 132 (Supplement 1): 4239.

https://doi.org/10.1182/blood-2018-99-118872

Published: 2018

Journal Articles

Immunophenotypic Characteristics of Olygomonocytic Chronic Myelomonocytic Leukemia Support Its Diagnosis As a Distinctive Entity in the Continuum of Chronic Myelomonocytic Leukemia

Xavier Calvo, MD, Ivonne Parraga, Fellow, Lourdes Florensa, MD PhD, Sara Montesdeoca Romero, MD, Anna Puiggros, PhD, Marta Salido, PhD, Blanca Espinet, PhD, Anna Angona, MD PhD, Ana Ferrer, MD PhD, Carme Pedro, MD, Leonor Arenillas, MD PhD

Blood (2018) 132 (Supplement 1): 5520.

https://doi.org/10.1182/blood-2018-99-119906

Published: 2018

Journal Articles

Dose Reductions in Ibrutinib Therapy Are Not Associated with Inferior Outcomes in Patients with Chronic Lymphocytic Leukemia (CLL)

Othman S. Akhtar, MD, Kris Attwood, PhD MS, Ian Lund, PA-C, Ryan Hare, PharmD, Francisco J. Hernandez-Ilizaliturri, MD, Pallawi Torka, MD

Blood (2018) 132 (Supplement 1): 5567.

https://doi.org/10.1182/blood-2018-99-112334

Published: 2018

Journal Articles

Thrombocytosis in Iron Deficiency Anemia

Hemendra Mhadgut, MD, Hadiza Galadima, PhD, Hassan Raymond Tahhan, MD

Blood (2018) 132 (Supplement 1): 4985.

https://doi.org/10.1182/blood-2018-99-119352

Published: 2018

Journal Articles

Risk Factors Predisposing Development of Priapism in Sickle Cell Disease Patients

Salam Alkindi, FRCP, BA, MBBChir, Said AlMufargi, Anil Pathare, MD PhD FCPS, MBBS

Blood (2018) 132 (Supplement 1): 4917.

https://doi.org/10.1182/blood-2018-99-118475

Published: 2018

Journal Articles

Thromboembolic Complications in Patients with Sickle Cell Disease

Salam Alkindi, FRCP, BA, MBBChir, Anwaar Al-Ghadani, Samah Al-zeheimi, Anil Pathare, MD PhD FCPS, MBBS

Blood (2018) 132 (Supplement 1): 4913.

https://doi.org/10.1182/blood-2018-99-118388

Published: 2018

Journal Articles

Clinical Impact of Iron Overload on Morbidity in Patients with Sickle Cell Disease

Anuj Shrestha, MD MBBS, Punita Grover, MD, Zaheer Ahmed, MD, Daulath Singh, MD, Simran Arora, MD, Sashidhar Manthravadi, MBBS, Jill Moormeier, MD MPH, An-lin Cheng, PhD, Lejla Music-Aplenc, MD, Sheshadri Madhusudhana, MD

Blood (2017) 130 (Supplement 1): 4787.

https://doi.org/10.1182/blood.V130.Suppl_1.4787.4787

Published: 2017

Journal Articles

Protein Kinase C Delta in Diffuse Large B-Cell Lymphoma Post-Rituximab Era: Potential Prognostic Marker in Germinal Center B-Cell Lymphoma

Qunling Zhang, MD PhD, Juan Gu, MD PhD, Kai Xue, MD, Cory Mavis, BSc, MSc, Francisco J. Hernandez-Ilizaliturri, MD, Junning Cao, Xiaonan Hong, Ye Guo

Blood (2017) 130 (Supplement 1): 2839.

https://doi.org/10.1182/blood.V130.Suppl_1.2839.2839

Published: 2017

Journal Articles

Multicenter Case Series of Primary Adrenal Lymphoma (PAL)

Blood (2017) 130 (Supplement 1): 1562.

https://doi.org/10.1182/blood.V130.Suppl_1.1562.1562

Published: 2017

Journal Articles

Red Cell Distribution Width (RDW) As Prognostic Factor in Acute Leukemia Patients Undergoing Allogeneic Hematopoietic Transplantation

Giuseppe Milone, MDPhD, Annalia DiMarco, Giuseppe Sapienza, Salvatore Leotta, Luca Scalise, Carla Consoli, Maria Cristina Pirosa, Alessandra Cupri, Gaetano Moschetti, Maria Grazia Camuglia, Maria Sciacca, AnnaElisa Marchese, PhD

Blood (2017) 130 (Supplement 1): 5098.

https://doi.org/10.1182/blood.V130.Suppl_1.5098.5098

Published: 2017

Journal Articles

Portal Vein Thrombosis in Adult Omani Patients-a Retrospective Study

Khalid Al Hashmi, MD, Lamia Al Aamri, Anil Pathare, MD PhD FCPS, MBBS, Al Lamki Sulayma, Murtadha K. Al-Khabori, BSc,MDFRCPC,MSc

Blood (2017) 130 (Supplement 1): 4909.

https://doi.org/10.1182/blood.V130.Suppl_1.4909.4909

Published: 2017

Journal Articles

The -2518A/G (rs1026411) Regulatory Region Polymorphism of the Monocyte Chemoattractant Protein-1 (MCP-1) Is Associated with Secondary Myelofibrosis

Elena Masselli, MD, Cecilia Carubbi, PhD, Benedetta Cambò, MD, Giulia Pozzi, MS, Giuliana Gobbi, PhD, Prisco Mirandola, PhD, Elena Follini, MD, Luca Pagliaro, MD, Francesco Bonatti, PhD, Antonio Percesepe, MD PhD, Franco Aversa, MD, Marco Vitale, MD

Blood (2017) 130 (Supplement 1): 5286.

https://doi.org/10.1182/blood.V130.Suppl_1.5286.5286

Published: 2017

Journal Articles

A New Clinically-Based Subclassification Proposal in CMML with Significant Prognostic Implications to Overcome the MDS/MPN Categorizing Dilemma

Blood (2016) 128 (22): 4320.

https://doi.org/10.1182/blood.V128.22.4320.4320

Published: 2016

NARROW

Clinical, Hematological, Genetic, and Pathological Significance in Newly Diagnosed High Grade B-Cell Lymphoma and Diffuse Large B-Cell Lymphoma

A Longitudinal Study in Elderly Patients with Non-Transfusion Dependent Thalassemia (NTDT) Emphasizes the Size of Splenomegaly Predicts Transfusion Requirement Later in Life

Patterns of Renal Recovery and Toxicity with Novel Agent-Based Induction Triplets in Newly Diagnosed Multiple Myeloma - an Analysis of Two Prospective Studies By the German DSMM Myeloma Study Group

Predictive Value of Cellular Blood Indices for All-Cause Mortality in Acute Pulmonary Embolism

Neutropenia in Children Treated with Deferiprone or Deferasirox: A Report of the Largest Randomized Trial of Oral Chelators in Transfusion-Dependent Pediatric Patients

Outcomes of Follicular Lymphoma Patients Treated with Frontline Bendamustine and Rituximab: Impact of Histologic Grade and Early Progression on Overall Survival

Deubiquitinase OTUD7B Is Potential Prognostic Biomarker in Diffuse Large B-Cell Lymphoma

Immunophenotypic Characteristics of Olygomonocytic Chronic Myelomonocytic Leukemia Support Its Diagnosis As a Distinctive Entity in the Continuum of Chronic Myelomonocytic Leukemia

Dose Reductions in Ibrutinib Therapy Are Not Associated with Inferior Outcomes in Patients with Chronic Lymphocytic Leukemia (CLL)

Thrombocytosis in Iron Deficiency Anemia

Risk Factors Predisposing Development of Priapism in Sickle Cell Disease Patients

Thromboembolic Complications in Patients with Sickle Cell Disease

Clinical Impact of Iron Overload on Morbidity in Patients with Sickle Cell Disease

Protein Kinase C Delta in Diffuse Large B-Cell Lymphoma Post-Rituximab Era: Potential Prognostic Marker in Germinal Center B-Cell Lymphoma

Multicenter Case Series of Primary Adrenal Lymphoma (PAL)

Red Cell Distribution Width (RDW) As Prognostic Factor in Acute Leukemia Patients Undergoing Allogeneic Hematopoietic Transplantation

Portal Vein Thrombosis in Adult Omani Patients-a Retrospective Study

The -2518A/G (rs1026411) Regulatory Region Polymorphism of the Monocyte Chemoattractant Protein-1 (MCP-1) Is Associated with Secondary Myelofibrosis

A New Clinically-Based Subclassification Proposal in CMML with Significant Prognostic Implications to Overcome the MDS/MPN Categorizing Dilemma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only